TrialArthritis research & therapy2009

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.

Jacques Tebib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.